Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Zinc  COVID-19 treatment studies for Zinc  C19 studies: Zinc  Zinc   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Association of Trace Element Status in COVID-19 Patients with Disease Severity
Bego et al., Journal of Trace Elements in Medicine and Biology, doi:10.1016/j.jtemb.2022.127055
Bego et al., Association of Trace Element Status in COVID-19 Patients with Disease Severity, Journal of Trace Elements in Medicine and Biology, doi:10.1016/j.jtemb.2022.127055
Aug 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Analysis of 210 hospitalized patients in Bosnia and Herzegovina with serum levels measured on admission, showing significantly lower zinc and selenium levels in patients that died or had severe cases, compared to mild cases.
Bego et al., 4 Aug 2022, Bosnia and Herzegovina, peer-reviewed, 10 authors, study period January 2021 - July 2021.
Contact: tamer.bego@ffsa.unsa.ba.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperZincAll
Abstract: Journal Pre-proof Association of Trace Element Status in COVID-19 Patients with Disease Severity Tamer Bego, Neven Meseldžić, Besim Prnjavorac, Lejla Prnjavorac, Damir Marjanović, Rui Azevedo, Edgar Pinto, Mary Duro, Cristina Couto, Agostinho Almeida PII: S0946-672X(22)00135-3 DOI: https://doi.org/10.1016/j.jtemb.2022.127055 Reference: JTEMB127055 To appear in: Journal of Trace Elements in Medicine and Biology Received date: 29 December 2021 Revised date: 4 July 2022 Accepted date: 2 August 2022 Please cite this article as: Tamer Bego, Neven Meseldžić, Besim Prnjavorac, Lejla Prnjavorac, Damir Marjanović, Rui Azevedo, Edgar Pinto, Mary Duro, Cristina Couto and Agostinho Almeida, Association of Trace Element Status in COVID-19 Patients with Disease Severity, Journal of Trace Elements in Medicine and Biology, (2021) doi:https://doi.org/10.1016/j.jtemb.2022.127055 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2021 Published by Elsevier. 1 Association of Trace Element Status in COVID-19 Patients with Disease Severity 2 Tamer Bego1*, Neven Meseldžić1, Besim Prnjavorac6,7, Lejla Prnjavorac7, Damir Marjanović8, Rui Azevedo2, 3 Edgar Pinto2,3, Mary Duro2,5, Cristina Couto2,4 and Agostinho Almeida2* Affiliations of the authors: 4 5 1 Diagnostics, 71000 Sarajevo, Bosnia and Herzegovina 6 7 University of Sarajevo, Faculty of Pharmacy, Department of Pharmaceutical Biochemistry and Laboratory 2 LAQV/REQUIMTE, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal 8 Department of Environmental Health, School of Health, P.Porto, 4200-072 Porto, Portugal 10 4 TOXRUN – Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, of 9 3 Portugal 11 Fernando Pessoa Health School, 4249-004 Porto, Portugal 13 6 University of Sarajevo, Faculty of Pharmacy, 71000 Sarajevo, Bosnia and Herzegovina 14 7 General Hospital Tešanj, 74260 Tešanj, Bosnia and Herzegovina 15 8 International Burch University, 71000 Sarajevo, Bosnia and Herzegovina -p ro 12 5 16 * Corresponding author: Prof. Dr. Tamer Bego, University of Sarajevo, Faculty of Pharmacy, Department of Pharmaceutical Biochemistry and Laboratory Diagnostics, 71000 Sarajevo, Bosnia and Herzegovina, e-mail 18 address: tamer.bego@ffsa.unsa.ba; +387 33 586 188 re 17 lP 19 Abstract 21 Caused by the new SARS-CoV-2 coronavirus, COVID-19 (coronavirus disease 2019) evolves with clinical 22 symptoms that vary widely in severity, from mild symptoms to critical conditions, which can even result in the 23 patient's death. A critical aspect related to an individual response to SARS-CoV-2 infection is the competence of 24 the immune system, and it is well known that several trace elements are essential for an adequate immune re- 25 sponse and have anti-inflammatory and antioxidant properties that are of particular importance in fighting infec- 26 tion. Thus, it..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit